Generics Group Says 'Skinny Label' Suit Should Not Proceed
By Britain Eakin · August 20, 2021, 10:11 PM EDT
The Association for Accessible Medicines has urged a Delaware federal judge to reject part of a magistrate judge's report and recommendation not to dismiss Amarin Pharma Inc.'s infringement suit against Hikma...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login